These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 29653577)

  • 21. microRNA biosensors: Opportunities and challenges among conventional and commercially available techniques.
    Kilic T; Erdem A; Ozsoz M; Carrara S
    Biosens Bioelectron; 2018 Jan; 99():525-546. PubMed ID: 28823978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology.
    Chistiakov DA; Sobenin IA; Orekhov AN
    Drug Deliv; 2012 Nov; 19(8):392-405. PubMed ID: 23173580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRAIL and microRNAs in the treatment of prostate cancer: therapeutic potential and role of nanotechnology.
    Farooqi AA; De Rosa G
    Appl Microbiol Biotechnol; 2013 Oct; 97(20):8849-57. PubMed ID: 24037407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Review on the Role of Nanosensors in Detecting Cellular miRNA Expression in Colorectal Cancer.
    Girigoswami K; Girigoswami A
    Endocr Metab Immune Disord Drug Targets; 2021; 21(1):12-26. PubMed ID: 32410567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biosynthesized metal oxide nanoparticles for sustainable agriculture: next-generation nanotechnology for crop production, protection and management.
    Maity D; Gupta U; Saha S
    Nanoscale; 2022 Oct; 14(38):13950-13989. PubMed ID: 36124943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promises of Nanotherapeutics in Obesity.
    Ash GI; Kim D; Choudhury M
    Trends Endocrinol Metab; 2019 Jun; 30(6):369-383. PubMed ID: 31126754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-based therapeutics in cardiovascular disease: screening and delivery to the target.
    Mellis D; Caporali A
    Biochem Soc Trans; 2018 Feb; 46(1):11-21. PubMed ID: 29196609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-viral nanocarriers for intracellular delivery of microRNA therapeutics.
    Bai Z; Wei J; Yu C; Han X; Qin X; Zhang C; Liao W; Li L; Huang W
    J Mater Chem B; 2019 Feb; 7(8):1209-1225. PubMed ID: 32255160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: Prospects for the therapeutic management of breast cancer.
    Ansari MA; Thiruvengadam M; Farooqui Z; Rajakumar G; Sajid Jamal QM; Alzohairy MA; Almatroudi A; Alomary MN; Chung IM; Al-Suhaimi EA
    Semin Cancer Biol; 2021 Feb; 69():109-128. PubMed ID: 31891780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miRNA nanotherapeutics for cancer.
    Ganju A; Khan S; Hafeez BB; Behrman SW; Yallapu MM; Chauhan SC; Jaggi M
    Drug Discov Today; 2017 Feb; 22(2):424-432. PubMed ID: 27815139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanotechnological based miRNA intervention in the therapeutic management of neuroblastoma.
    Pottoo FH; Barkat MA; Harshita ; Ansari MA; Javed MN; Sajid Jamal QM; Kamal MA
    Semin Cancer Biol; 2021 Feb; 69():100-108. PubMed ID: 31562954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can nanotechnology improve cancer diagnosis through miRNA detection?
    Fiammengo R
    Biomark Med; 2017 Jan; 11(1):69-86. PubMed ID: 27917642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA origami nanopores: developments, challenges and perspectives.
    Hernández-Ainsa S; Keyser UF
    Nanoscale; 2014 Nov; 6(23):14121-32. PubMed ID: 25325422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delivery of therapeutic miRNA using polymer-based formulation.
    Ban E; Kwon TH; Kim A
    Drug Deliv Transl Res; 2019 Dec; 9(6):1043-1056. PubMed ID: 31049843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.
    Shu D; Li H; Shu Y; Xiong G; Carson WE; Haque F; Xu R; Guo P
    ACS Nano; 2015 Oct; 9(10):9731-40. PubMed ID: 26387848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA nanotechnology approaches for microRNA detection and diagnosis.
    Chandrasekaran AR; Punnoose JA; Zhou L; Dey P; Dey BK; Halvorsen K
    Nucleic Acids Res; 2019 Nov; 47(20):10489-10505. PubMed ID: 31287874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanomaterials in the Pharmaceuticals: Occurrence, Behaviour and Applications.
    Uddin I; Venkatachalam S; Mukhopadhyay A; Usmani MA
    Curr Pharm Des; 2016; 22(11):1472-84. PubMed ID: 26775674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent developments in nanotechnology transforming the agricultural sector: a transition replete with opportunities.
    Kim DY; Kadam A; Shinde S; Saratale RG; Patra J; Ghodake G
    J Sci Food Agric; 2018 Feb; 98(3):849-864. PubMed ID: 29065236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted delivery of small noncoding RNA for glioblastoma.
    Yoo JY; Yeh M; Kaur B; Lee TJ
    Cancer Lett; 2021 Mar; 500():274-280. PubMed ID: 33176185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanobiotechnology-based drug delivery in brain targeting.
    Dinda SC; Pattnaik G
    Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.